1、Q32024EUROPEANVenture ReportSponsored byQ32024From series A to IPO,grow your business without limitsWith a 225-year legacy and deep expertise fueling startups and high-growth companies,J.P.Morgan can support you at every stage of your companys journey.Lets work together to build your future.See how

2、we can support your growth at 2024 JPMorgan Chase&Co.All rights reserved.JPMorgan Chase Bank,N.A.Member FDIC.Visit for full disclosures and disclaimers related to this content.2126131PitchBook Data,Inc.Nizar Tarhuni Executive Vice President of Research and Market IntelligenceDylan Cox,CFA Head of Pr

3、ivate Markets ResearchInstitutional Research GroupAnalysisContentsSponsored by3Q3 2024 EUROPEAN VENTURE REPORTIntroduction4Deals 5Venture debt8A word from J.P.Morgan10Spotlight:UK market update12Exits14Fundraising17Published on 16 October 2024Click here for PitchBooks report methodologies.DataOscar

4、Allaway Data APublishingReport designed by Julia MidkiffNavina Rajan Senior Analyst,EMEA Private Capital Sponsored by4Q3 2024 EUROPEAN VENTURE REPORTINTRODUCTIONIntroductionDeal value is pacing below last year.The 10 largest deals in Q3 spanned various verticals,and several were up rounds.Artificial

5、 intelligence(AI)was expectedly more prevalent among the deals.A female technology(femtech)startup,Flo Health,made the top five deals for the first time,becoming the first femtech unicorn in Europe.Vertical-specific data shows AI investment pacing above last year,alongside software as a service(SaaS

6、)and life sciences,where oncology and healthtech funding has been prominent.Among the venture stages,venture growth showed resilience after its trailing performance last year.In this report,we also discuss regional trends and spotlight the UK,exploring macroeconomic and political implications for th